Insider filing · TEVA
Eliyahu Sharon Kalif
EVP, Chief Financial Officer
profile →
Teva Pharmaceutical Industries Limited
TEVA · Healthcare · 56 filings in 24 months
ticker →
Eliyahu Sharon Kalif sold $5.5M of Teva Pharmaceutical Industries Limited (TEVA)
Executed May 14, disclosed May 18, 4 days later.
Value, as filed
$5.5M
153,251 sh × $35.61
Executed
May 14
the trade date, as filed
Disclosed
May 18
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
EKEliyahu Sharon Kalif (EVP, Chief Financial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $11.6M of TEVA (345,810 sh × $33.64, as filed), executed Feb 26.
The name
TEVAHealthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Eliyahu Sharon Kalif in TEVA
TEVASALE
Teva Pharmaceutical Industries Limited
$3.6M106,563 sh × $34.10
Exec Jun 11
Filed Jun 16 · 5:30 PM ET † TEVASALE Teva Pharmaceutical Industries Limited $11.6M
345,810 sh × $33.64
Exec Feb 26
Filed Mar 2 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $953K
55,775 sh × $17.08
Exec Jun 12 2025
Filed Jun 16 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $904K
55,750 sh × $16.21
Exec Feb 28 2025
Filed Mar 4 2025 · 5:30 PM ET